Research

The CVINJ is a new model of an interdiscliplinary and comprehensive cardiovascular disease program that espouses openness, collaboration, and multidisciplinary research teams. At the present time, the major areas of research focus at CVINJ are clinical trials, cardiovascular pharmacology research, disease management and clinical outcomes research, and biomedical engineering. The CVINJ's long-term research goals include identifying the genetic and environmental factors associated with heart disease and translating that new knowledge into improved health for patients with ischemic, hypertrophic, congenital and idiopathic dilated cardiomyopathies.

The New Jersey Myocardial Infarction Data Acquisition System (MIDAS), developed by CVINJ, includes 20 years of data on more than 500,000 people in New Jersey who have had a myocardial infarction. MIDAS enables CVINJ faculty to identify important trends in cardiovascular diseases and achieve better clinical outcomes for patients. 

CVINJ faculty members have participated in the development of over 100 cardiovascular drugs and have been awarded more than $15 million in research funding. CVINJ's physicians and scientists have published in over 500 peer reviewed journals based on their world-class research.